AHA bulletin highlights Baxter’s efforts to increase access, supply of IV solutions

AHA today Oct. 24 a Special Bulletin with updates from Baxter on its efforts to increase access to and supply of IV solutions in response to the effects of Hurricane Helene on its manufacturing facility in North Carolina. Baxter anticipates restarting the highest-throughput IV solutions manufacturing line at the impacted plant within the next week. In addition, the Food and Drug Administration authorized temporary importation for a variety of products from two additional Baxter plants in Thailand and Singapore, bringing the total number of facilities authorized to import products to seven. See AHA's Special Bulletin for more updates.